Literature DB >> 11007790

High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells.

Z Zhang1, K Apse, J Pang, R C Stanton.   

Abstract

Recent studies have shown that hyperglycemia is a principal cause of cellular damage in patients with diabetes mellitus. A major consequence of hyperglycemia is increased oxidative stress. Glucose-6-phosphate dehydrogenase (G6PD) plays an essential role in the regulation of oxidative stress by primarily regulating NADPH, the main intracellular reductant. In this paper we show that increased glucose (10-25 mm) caused inhibition of G6PD resulting in decreased NADPH levels in bovine aortic endothelial cells (BAEC). Inhibition was seen within 15 min. High glucose-induced inhibition of G6PD predisposed cells to cell death. High glucose via increased activity of adenylate cyclase also stimulated an increase in cAMP levels in BAEC. Agents that increased cAMP caused a decrease in G6PD activity. Inhibition of cAMP-dependent protein kinase A ameliorated the high glucose-induced inhibition of G6PD. Finally, high glucose stimulated phosphorylation of G6PD. These results suggest that, in BAEC, high glucose stimulated increased cAMP, which led to increased protein kinase A activity, phosphorylation of G6PD, and inhibition of G6PD activity. We conclude that these changes in G6PD activity play an important role in high glucose-induced cell damage/death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007790     DOI: 10.1074/jbc.M007505200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Regulation of glucose-6-phosphate dehydrogenase by reversible phosphorylation in liver of a freeze tolerant frog.

Authors:  Christopher A Dieni; Kenneth B Storey
Journal:  J Comp Physiol B       Date:  2010-06-10       Impact factor: 2.200

2.  Hyperglycemia and oxidative stress: complex relationships with attractive prospects.

Authors:  Xavier Leverve
Journal:  Intensive Care Med       Date:  2003-04       Impact factor: 17.440

3.  Use of medications to lower urine protein level in patients with diabetic kidney disease.

Authors:  Robert C Stanton
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

4.  The small GTPase RacA mediates intracellular reactive oxygen species production, polarized growth, and virulence in the human fungal pathogen Aspergillus fumigatus.

Authors:  Haiyan Li; Bridget M Barker; Nora Grahl; Srisombat Puttikamonkul; Jeremey D Bell; Kelly D Craven; Robert A Cramer
Journal:  Eukaryot Cell       Date:  2010-12-23

Review 5.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

Review 6.  Metabolic Regulation of Angiogenesis in Diabetes and Aging.

Authors:  Naoki Sawada; Zolt Arany
Journal:  Physiology (Bethesda)       Date:  2017-07

7.  Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.

Authors:  Jane A Leopold; Aamir Dam; Bradley A Maron; Anne W Scribner; Ronglih Liao; Diane E Handy; Robert C Stanton; Bertram Pitt; Joseph Loscalzo
Journal:  Nat Med       Date:  2007-02-04       Impact factor: 53.440

8.  Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.

Authors:  Yi-Ping Wang; Li-Sha Zhou; Yu-Zheng Zhao; Shi-Wen Wang; Lei-Lei Chen; Li-Xia Liu; Zhi-Qiang Ling; Fu-Jun Hu; Yi-Ping Sun; Jing-Ye Zhang; Chen Yang; Yi Yang; Yue Xiong; Kun-Liang Guan; Dan Ye
Journal:  EMBO J       Date:  2014-04-25       Impact factor: 11.598

Review 9.  Endothelial cell metabolism in normal and diseased vasculature.

Authors:  Guy Eelen; Pauline de Zeeuw; Michael Simons; Peter Carmeliet
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

Review 10.  Syndromes of ketosis-prone diabetes mellitus.

Authors:  Ashok Balasubramanyam; Ramaswami Nalini; Christiane S Hampe; Mario Maldonado
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.